Vitamin D deficiency and insufficiency among patients with prostate cancer

Abstract

sample, were chosen from a prospective serum banking protocol. The relationship between age, body mass index, disease stage, Eastern Cooperative Oncology Group performance status, season and previous therapy on vitamin D status were evaluated using univariate and multivariate analyses. RESULTSThe mean 25-OH vitamin D level was 25.9 ng/mL in those with recurrent disease, 27.5 ng/mL in men with clinically localized prostate cancer and 24.5 ng/mL in controls. The frequency of vitamin D deficiency ( < 20 ng/mL) and insufficiency (20-31 ng/ mL) was 40% and 32% in men with recurrent prostate; 28% had vitamin D levels that were normal (32-100 ng/mL). Among men with localized prostate cancer, 18% were deficient, 50% were insufficient and 32% were normal. Among controls, 31% were deficient, 40% were insufficient and 29% were normal. Metastatic disease ( P = 0.005) and season of blood sampling (winter/spring; P = 0.01) were associated with vitamin D deficiency in patients with prostate cancer, while age, race, performance status and body mass index were not. CONCLUSIONSVitamin D deficiency and insufficiency were common among men with prostate cancer and apparently normal controls in the western New York region. KEYWORDS PATIENTS, SUBJECTS AND METHODSThe study included 120 ambulatory men with recurrent prostate cancer and 50 with clinically localized prostate cancer who were evaluated and serum samples assayed for 25-OH vitamin D levels. Then 100 controls (both sexes), matched for age and season of serum

The Association Between Breast Cancer Prognostic Indicators and Serum 25-OH Vitamin D Levels

“…The overall prevalence of vitamin D insufficiency and deficiency in our study is similar to other studies of vitamin D levels in breast cancer patients[36, 37, 45, 46] and other cancer sites. [47, 48] Sub-optimal vitamin D levels were more common in women with later stage disease, non-Caucasians, and those who received radiation therapy. It is possible that non-Caucasians had lower 25-OH vitamin D levels due to higher levels of melanin, which reduces the amount of endogenously produced vitamin D.[49] It is also possible that those with later-stage disease and those who received radiation therapy reduced their sunlight exposure and/or altered their diet due to the nature of their treatment.…”

Vitamin D-Related Gene Polymorphisms, Plasma 25-Hydroxy-Vitamin D, Cigarette Smoke and Non-Small Cell Lung Cancer (NSCLC) Risk

“…Risk factors associated with environment and lifestyle include family history of lung cancer, history of pulmonary diseases, nutrition, air pollution, cigarette smoke, and exposure to radiation, asbestos and radon. Furthermore, recent epidemiological studies have shown that exposure to solar radiation (in particular ultraviolet B (UVB) radiation) and vitamin D intake is connected with decreased incidence of many cancers including lung, breast, prostate and colon cancer [2,3,4,5,6]. The mortality of lung cancer is lowest during the autumn and summer months, which are associated with the highest vitamin D levels in a year [7].…”

Molecular pathways mediating the anti-inflammatory effects of calcitriol: implications for prostate cancer chemoprevention and treatment

“…light is essential for the synthesis of vitamin D in the skin, and epidemiological studies suggest that mortality rates due to PCa in the US are inversely related to sunlight exposure (Hanchette & Schwartz 1992, Schwartz & Skinner 2007. Many studies suggest that vitamin D deficiency, characterized by low circulating 25-hydroxyvitamin D levels, is associated with increased PCa risk and progression (Ahonen et al 2000, Giovannucci 2005, Tretli et al 2009, Trump et al 2009, although all studies do not support such a correlation (Platz et al 2004, Ahn et al 2008.…”